We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$1.55B
AUM Growth
+$134M
Cap. Flow
-$6.03M
Cap. Flow %
-0.39%
Top 10 Hldgs %
39.66%
Holding
86
New
5
Increased
35
Reduced
29
Closed
3

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$8.67M
2
CGNX icon
Cognex
CGNX
+$8.02M
3
RBA icon
RB Global
RBA
+$4.23M
4
HAE icon
Haemonetics
HAE
+$3.88M
5
HURN icon
Huron Consulting
HURN
+$3.77M

Sector Composition

Rank Sector Weight
1 Technology 35.94%
2 Healthcare 33.29%
3 Industrials 11.87%
4 Financials 6.94%
5 Consumer Discretionary 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANSS
26
DELISTED
Ansys
ANSS
$26.3M 1.7%
216,527
+705
+0.3% +$83.1K
DORM icon
27
Dorman Products
DORM
$4.18B
$25.4M 1.64%
307,010
+370
+0.1% +$30.2K
BLKB icon
28
Blackbaud
BLKB
$2.08B
$22.3M 1.44%
259,935
+2,675
+1% +$220K
IPGP icon
29
IPG Photonics
IPGP
$3.84B
$20.8M 1.34%
143,135
-675
-0.5% -$90.6K
FELE icon
30
Franklin Electric
FELE
$4.84B
$18.9M 1.22%
457,420
+4,315
+1% +$173K
HAE icon
31
Haemonetics
HAE
$4B
$17.4M 1.12%
439,396
-94,400
-18% -$3.88M
MORN icon
32
Morningstar
MORN
$7.53B
$16M 1.03%
203,795
-3,126
-2% -$236K
FORR icon
33
Forrester Research
FORR
$224M
$15.7M 1.01%
401,752
-4,900
-1% -$194K
HCSG icon
34
Healthcare Services Group
HCSG
$1.53B
$15.1M 0.98%
322,949
-4,255
-1% -$197K
MD icon
35
Pediatrix Medical
MD
$2.2B
$15.1M 0.97%
249,420
-43,790
-15% -$2.6M
CRL icon
36
Charles River Laboratories
CRL
$12.8B
$15M 0.97%
147,900
CSGP icon
37
CoStar Group
CSGP
$12.3B
$12.9M 0.83%
487,710
+34,580
+8% +$841K
MMSI icon
38
Merit Medical Systems
MMSI
$5.32B
$10.6M 0.69%
278,575
-1,875
-0.7% -$62.7K
RP
39
DELISTED
RealPage, Inc.
RP
$10.3M 0.67%
+287,705
New +$10.3M
RAMP icon
40
LiveRamp
RAMP
$2.3B
$10.3M 0.67%
397,500
+9,000
+2% +$245K
ACIW icon
41
ACI Worldwide
ACIW
$5.42B
$8.9M 0.57%
398,000
PRLB icon
42
Protolabs
PRLB
$2.13B
$8.88M 0.57%
132,061
+3,525
+3% +$213K
FAST icon
43
Fastenal
FAST
$59.5B
$5.75M 0.37%
527,868
-138,920
-21% -$1.56M
CVLT icon
44
Commault Systems
CVLT
$5.61B
$4.52M 0.29%
80,000
ABAX
45
DELISTED
Abaxis Inc
ABAX
$4.24M 0.27%
80,000
FWRD icon
46
Forward Air
FWRD
$654M
$3.97M 0.26%
74,475
+80
+0.1% +$4.09K
CPLA
47
DELISTED
Capella Education Company
CPLA
$3.94M 0.25%
45,970
+2,240
+5% +$199K
NATI
48
DELISTED
National Instruments Corp
NATI
$3.86M 0.25%
95,995
+8,230
+9% +$299K
FFIV icon
49
F5
FFIV
$22.7B
$3.84M 0.25%
30,195
+1,150
+4% +$151K
HD icon
50
Home Depot
HD
$355B
$3.61M 0.23%
23,539
-1,147
-5% -$176K

Similar funds

American Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, American Capital Management held 86 positions worth $1.55B, up 9.4% from $1.42B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

American Capital Management's Q2 2017 filing shows 5 new, 35 increased, 29 reduced and 3 closed positions. Its largest new stake was RealPage, Inc.: 287,705 shares worth $10.3M. The largest sale was Idexx Laboratories, an estimated $8.67M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q2 2017 buy was RealPage, Inc.: 287,705 shares worth $10.3M.
  • American Capital Management added most to CyberArk in Q2 2017, an estimated $18.4M increase.
  • American Capital Management's biggest Q2 2017 reduction was Idexx Laboratories, cutting an estimated $8.67M.
  • American Capital Management fully exited CEB Inc. in Q2 2017, selling an estimated $2.55M.
  • American Capital Management's ten largest holdings make up 40% of its $1.55B portfolio in Q2 2017.
  • American Capital Management opened 5 new positions and closed 3 in Q2 2017.
  • American Capital Management's portfolio value rose 9.4% quarter-over-quarter to $1.55B.

Based on American Capital Management's 13F filing for Q2 2017, filed 27 Jul 2017.